Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nasal vaccine
Pharma
NIH awards $15M contract to Intravacc's nasal gonorrhea vaccine
Intravacc secured the financial support as it works to move its NGoXIM nasally administered gonorrhea vaccine candidate into a phase 1 trial.
Nick Paul Taylor
Oct 11, 2022 8:20am
Ocugen sniffs out COVID opportunity, landing nasal vaccine
Oct 4, 2022 7:05am
Xanadu spins out of Yale with nasal COVID-19 vaccine tech
Feb 14, 2022 7:20am
BARDA backs IDRI to develop nasal RNA vaccine against flu
Dec 21, 2021 8:45am
Meissa posts early clinical data on nasal COVID-19 vaccine
Nov 2, 2021 8:05am
Russian team gets green light to trial nasal COVID-19 vaccine
Oct 19, 2021 6:30am
